Courtney Carson, MA

Policy and Advocacy Officer

Courtney Carson manages congressional outreach, policy development, and legislative analysis to support the US advocacy work of the coalition. In this capacity, she serves as GHTC’s primary interface with Congress and helps develop strategies to advance the coalition’s legislative priorities.

Courtney has a background in foreign policy and global health, serving as staff to Senator Chris Coons (D-DE) and managing his chairmanship of the Senate Caucus on Malaria and Neglected Tropical Diseases. Prior to joining GHTC, she managed outreach and policy development for a cross-sector coalition advancing international development, global health, and trade policy. She has also worked to enhance public-private partnerships for international development with ACDI/VOCA and the Corporate Council on Africa.

Courtney received her MA in International Economics and International Relations from the Johns Hopkins School of International Studies and her BA in International Relations, Economics, and French from the University of Delaware. In her free time, she likes to experiment with new recipes and plan her next travel adventure.

Articles Written by Courtney

Office of Management and Budget
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research

What global health advocates need to know about the President's "skinny" budget.

Read More
US Department of Homeland Security
President Trump wants to "cure the illnesses that plague us." That means we must invest in R&D

The United States can lead the world toward President Trump’s vision of accelerating cures for diseases that have plagued humanity, but not if we retreat from international engagement and development efforts—including strong engagement in global health R&D.

Read More
Flickr/Mark Taylor
Price addresses innovation, infectious diseases, NIH support at nomination hearings

At his nomination hearings, Secretary of Health and Human Services-designee Tom Price addressed global health and infectious diseases; innovation for rare diseases; support for health innovation, NIH, and priority setting for NIH-funded research. GHTC covers what he had to say.

Read More
Flickr/Gage Skidmore
Trump administration and global health research: What we’re watching for in 2017

As all eyes look toward President-elect Donald Trump's inauguration, GHTC examines the policy issues we'll be tracking on in 2017.

Read More
CDC/James Gathaney
Tillerson talks global health and development at Senate confirmation hearing

At his nomination hearing, Secretary of State–designee Rex Tillerson was questioned on women’s empowerment, family planning, development aid, and the President’s Emergency Plan for AIDS Relief (PEPFAR). GHTC covers what he had to say.

Read More
US Navy
Senate votes to protect medical research at DoD

Today the US Senate voted to protect critical medical research programs at the Department of Defense (DoD).

Read More
President will redirect Ebola funds for Zika, but where is the money from and where will it go?

The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?

Read More
CDC/Dr. Scott Smith
Global health R&D in the President’s FY17 budget request

On Monday, President Obama released his proposed budget for fiscal year 2017 (FY17).

Read More
Setting the stage: UN High-Level Panel on Access to Medicines to consider IP, trade, human rights, and access to medicine

In November 2015, United Nations (UN) Secretary-General Ban Ki-moon convened a High-Level Panel on Access to Medicines to discuss and develop solutions to promote innovation and access to essential medicines, vaccines, diagnostics, and other health technologies needed to ensure health and well-being around the world.

Read More
Obama highlights global health and innovation in State of the Union

GHTC has long championed US leadership in global health and innovation, and we were encouraged to see President Barack Obama highlight these themes in his State of the Union address.

Read More
PATH/Patrick McKern
Global Health Innovation Act has passed the House of Representatives

Last month, Representatives Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) introduced a new piece of legislation—the Global Health Innovation Act (H.R. 2241)—that would strengthen global health research and development (R&D) programming at the US Agency for International Development (USAID).

Read More
TPP: What does it mean for global health and what’s next?

After ten years of debate, on November 5, 2015, international negotiators released the final text of the largest regional trade agreement in history—the Trans Pacific Partnership (TPP).

Read More
New legislation would strengthen USAID’s role in global health R&D

Update: The Global Health Technologies Coalition is excited to announce that the Global Health Innovation Act (H.R. 2241) passed the House of Representatives on December 18.

Read More



Steering Committee


Rachel M. Cohen, MA

Regional Executive Director, North America

Drugs for Neglected Diseases initiative

Learn More about Rachel

Jodie Curtis

Washington Representative

American Society of Tropical Medicine and Hygiene

Learn More about Jodie

Jonathan Daniels

Manager of Policy and Advocacy


Learn More about Jonathan

Karen A. Goraleski, MA

Executive Director

American Society of Tropical Medicine and Hygiene

Learn More about Karen

Heather Ignatius, MA

Multilateral, US and Europe Policy & Advocacy Team Lead


Learn More about Heather

Sharyn Tenn, MA

Senior Advisor for External Affairs

International Partnership for Microbicides

Learn More about Sharyn